H1B Report
Side-by-side comparison

INFOSYS LIMITED vs King's Daughters Medical Specialties, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
INFOSYS LIMITED
TXRank #1FEIN 58-1760235
Entity B
King's Daughters Medical Specialties, Inc.
KYRank #FEIN 26-4183569

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricINFOSYS LIMITEDKing's Daughters Medical Specialties, Inc.
Total filings205,26365
Certified %99.55%92.31%
Denied %0.21%4.62%
Withdrawn %0.20%0.00%
Cert-withdrawn %0.05%3.08%
Rank#1
Active yearsFY2010–FY2026FY2011–FY2026
Worksite stateTXKY

Outcomes — INFOSYS LIMITED

DOL case-status mix.

Outcome breakdown: Certified 99.5%, Cert-withdrawn 0.0%, Withdrawn 0.2%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%
Certified99.5%
Cert-withdrawn0.0%
Withdrawn0.2%
Denied0.2%

Outcomes — King's Daughters Medical Specialties, Inc.

DOL case-status mix.

Outcome breakdown: Certified 92.3%, Cert-withdrawn 3.1%, Denied 4.6%
Outcome breakdown
OutcomeShare
Certified92.3%
Cert-withdrawn3.1%
Denied4.6%
Certified92.3%
Cert-withdrawn3.1%
Denied4.6%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

INFOSYS LIMITED
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,164
FY20111,681
FY201214,701
FY201332,232
FY201423,749
FY201533,214
FY201625,335
FY201720,571
FY201811,569
FY201921,420
FY202016
FY202129
FY202222
FY20232,269
FY20245,943
FY20255,790
FY20264,558
King's Daughters Medical Specialties, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY20119
FY20122
FY20135
FY20145
FY20156
FY20163
FY20177
FY20180
FY20199
FY20200
FY20210
FY20220
FY20230
FY20244
FY20256
FY20269

Top 5 occupations — INFOSYS LIMITED

Top 5 occupations — King's Daughters Medical Specialties, Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.